Boston Scientific Return on Investment 2006-2019 | BSX

Current and historical return on investment (ROI) values for Boston Scientific (BSX) over the last 10 years.
Boston Scientific ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2019-06-30 $1.63B $17.02B 10.80%
2019-03-31 $1.64B $16.82B 11.71%
2018-12-31 $1.51B $13.53B 11.81%
2018-09-30 $1.51B $13.10B 12.48%
2018-06-30 $1.50B $12.55B 12.67%
2018-03-31 $1.33B $11.83B 11.38%
2017-12-31 $1.29B $10.83B 10.83%
2017-09-30 $1.11B $12.00B 9.07%
2017-06-30 $1.08B $12.05B 8.90%
2017-03-31 $0.52B $12.56B 4.34%
2016-12-31 $0.45B $12.15B 3.80%
2016-09-30 $0.08B $11.65B 0.68%
2016-06-30 $-0.57B $11.39B -4.78%
2016-03-31 $-0.01B $11.88B -0.12%
2015-12-31 $-0.28B $11.99B -2.45%
2015-09-30 $-0.55B $12.21B -4.93%
2015-06-30 $-0.19B $11.65B -1.72%
2015-03-31 $-0.47B $10.35B -4.47%
2014-12-31 $-0.30B $10.30B -2.81%
2014-09-30 $0.32B $10.95B 2.95%
2014-06-30 $0.36B $10.80B 3.32%
2014-03-31 $0.65B $10.78B 6.07%
2013-12-31 $0.12B $10.78B 1.13%
2013-09-30 $0.11B $10.81B 1.02%
2013-06-30 $-0.59B $10.25B -5.43%
2013-03-31 $-4.39B $10.75B -39.11%
2012-12-31 $-3.87B $11.12B -31.05%
2012-09-30 $-3.81B $11.08B -28.08%
2012-06-30 $-3.05B $11.98B -20.64%
2012-03-31 $0.78B $15.65B 4.96%
2011-12-31 $0.90B $15.61B 5.72%
2011-09-30 $1.08B $15.78B 6.78%
2011-06-30 $1.16B $15.74B 7.22%
2011-03-31 $1.15B $16.04B 7.14%
2010-12-31 $-0.66B $16.23B -4.04%
2010-09-30 $-2.24B $16.17B -13.36%
2010-06-30 $-2.44B $16.08B -13.95%
2010-03-31 $-2.39B $16.45B -13.09%
2009-12-31 $-0.89B $18.22B -4.70%
2009-09-30 $-2.08B $19.07B -10.68%
2009-06-30 $-2.10B $19.33B -10.35%
2009-03-31 $-2.07B $19.52B -9.81%
2008-12-31 $-1.51B $19.92B -6.86%
2008-09-30 $0.48B $22.46B 2.12%
2008-06-30 $0.31B $22.65B 1.34%
2008-03-31 $0.28B $22.70B 1.22%
2007-12-31 $-0.01B $23.03B -0.06%
2007-09-30 $0.70B $23.42B 2.91%
2007-06-30 $1.04B $24.05B 4.31%
2007-03-31 $-3.16B $24.45B -13.14%
2006-12-31 $-2.95B $24.19B -15.05%
2006-09-30 $-2.77B $23.91B -18.35%
2006-06-30 $-3.30B $23.78B -30.86%
2006-03-31 $0.95B $6.51B 15.41%
2005-12-31 $0.97B $6.15B 16.33%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $59.981B $9.823B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $148.939B 20.91
Abbott Laboratories (ABT) United States $147.101B 27.65
Stryker (SYK) United States $82.696B 28.60
Baxter (BAX) United States $44.653B 27.08
EssilorLuxottica Societe Anonyme (ESLOY) France $31.497B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.674B 18.35
Lonza Group Ag (LZAGY) Switzerland $25.863B 0.00
Coloplast (CLPBY) Denmark $25.834B 41.24
Terumo (TRUMY) Japan $23.226B 26.71
Smith & Nephew SNATS (SNN) United Kingdom $20.906B 0.00
ResMed (RMD) United States $19.182B 36.58
Sunny Optical Technology (SNPTF) China $16.804B 0.00
Bio-Rad Laboratories (BIO) United States $10.124B 54.27
Insulet (PODD) United States $9.197B 544.96
Canopy Growth (CGC) Canada $9.163B 0.00
Perrigo (PRGO) Ireland $7.388B 13.61
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $6.984B 20.82
Haemonetics (HAE) United States $6.525B 49.24
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.265B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.167B 0.00
Neogen (NEOG) United States $4.002B 66.44
NuVasive (NUVA) United States $3.387B 27.00
ICU Medical (ICUI) United States $3.307B 21.45
Hutchison China MediTech (HCM) China $2.719B 0.00
Quidel (QDEL) United States $2.651B 26.33
Agios Pharmaceuticals (AGIO) United States $2.117B 0.00
National Vision Holdings (EYE) United States $2.015B 43.49
Cardiovascular Systems (CSII) United States $1.761B 0.00
Aphria (APHA) $1.519B 0.00
VAREX IMAGING (VREX) United States $1.090B 25.12
AtriCure (ATRC) United States $1.008B 0.00
Lantheus Holdings (LNTH) United States $1.003B 26.37
Omeros (OMER) United States $0.896B 0.00
Phibro Animal Health (PAHC) United States $0.881B 14.34
Eagle Pharmaceuticals (EGRX) United States $0.802B 20.45
NanoString Technologies (NSTG) United States $0.801B 0.00
Cerus (CERS) United States $0.745B 0.00
PetIQ (PETQ) United States $0.730B 17.25
LeMaitre Vascular (LMAT) United States $0.709B 42.01
MacroGenics (MGNX) United States $0.636B 0.00
Surmodics (SRDX) United States $0.620B 117.92
TG Therapeutics (TGTX) United States $0.607B 0.00
Quanterix (QTRX) United States $0.599B 0.00
OraSure Technologies (OSUR) United States $0.462B 21.40
Meridian Bioscience (VIVO) United States $0.407B 12.71
BioLife Solutions (BLFS) United States $0.396B 130.13
Utah Medical Products (UTMD) United States $0.368B 26.98
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.351B 0.00
Owens & Minor (OMI) United States $0.349B 10.47
Zynex (ZYXI) United States $0.315B 33.45
United Health Products (UEEC) United States $0.270B 0.00
Bovie Medical (APYX) United States $0.247B 0.00
Rockwell Medical (RMTI) United States $0.207B 0.00
Cytosorbents (CTSO) United States $0.178B 0.00
Vapotherm (VAPO) United States $0.174B 0.00
Chimerix (CMRX) United States $0.143B 0.00
Fonar (FONR) United States $0.142B 10.11
Chembio Diagnostics (CEMI) United States $0.122B 0.00
Female Health (VERU) United States $0.122B 0.00
InfuSystems Holdings (INFU) United States $0.105B 0.00
United-Guardian (UG) United States $0.085B 20.07
Nephros (NEPH) United States $0.068B 0.00
MRI Interventions (MRIC) United States $0.066B 0.00
Surface Oncology (SURF) United States $0.056B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
Senestech (SNES) United States $0.027B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Myomo (MYO) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00